Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis - Authors' reply
- PMID: 35364037
- DOI: 10.1016/S2213-2600(22)00064-9
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis - Authors' reply
Conflict of interest statement
ESL, SR, and WJF report a grant from the Netherlands Organisation for Health Research and Development to do the study. WJF further reports receiving grants from Sanofi and Novartis; receiving consulting fees and speaker honoraria from Sanofi and GSK; participating on a data-safety monitoring board for Lyra; is Secretary General of the European Rhinologic Society, chairperson of European Position Paper on Rhinosinusitis and Nasal Polyps, founding member of European Forum for Research and Education in Allergy and Airway Diseases, and a member of the Medical Advisory Board of the Dutch Patient Society for CRSwNP (all unpaid). SR reports grants, consulting fees, and honoraria from Sanofi and Novartis, and roles as a steering committee member (unpaid) for EPOS and for the European Chronic Rhinosinusitis Outcome Registry, and being a member (unpaid) of the Medical Advisory Board of the Dutch Patient Society for CRSwNP. All other authors report no competing interests.
Comment on
-
Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial.Lancet Respir Med. 2022 Apr;10(4):337-346. doi: 10.1016/S2213-2600(21)00457-4. Epub 2022 Jan 7. Lancet Respir Med. 2022. PMID: 35012708 Clinical Trial.
-
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis.Lancet Respir Med. 2022 Apr;10(4):e38. doi: 10.1016/S2213-2600(22)00061-3. Lancet Respir Med. 2022. PMID: 35364036 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
